Cholesterol Research Center, Children's Hospital Oakland Research Institute
Berkeley, California, 94705, United States
NCT Number: NCT01404897
The Dietary Approaches to Stop Hypertension (DASH) trial has been shown to reduce blood pressure and plasma total and LDL-cholesterol (C) compared to a Western diet, but shows no benefit on other blood lipid variables associated with cardiovascular disease (CVD) risk, namely HDL-cholesterol and triglycerides. The overall objective of this study is to determine whether modification of the DASH diet by substituting carbohydrate with fat will result in improvements in multiple biomarkers of CVD risk. Specifically, the investigators will test the hypotheses that modification of the DASH diet by reducing carbohydrate, primarily in the form of simple sugars and glycemic starches, and allowing for a more liberal intake of total and saturated fat, primarily from dairy foods, will: (1) improve lipoprotein markers of CVD risk (reduced total/HDL-C ratio, apolipoprotein B, small LDL particles, and increased HDL-C, apoAI, and large HDL particles); and (2) result in comparable reductions of systolic and diastolic blood pressure to those achieved with the standard DASH diet. The investigators will also assess the effects of the modified DASH diet on markers of insulin resistance and inflammation. Our main hypotheses will be tested by a controlled dietary intervention conducted in 40 healthy men and women who will be randomly allocated to consume, for 3 weeks each, a control Western diet, a standard DASH diet, and a modified low-carbohydrate DASH diet, separated by 2-week washout periods.
Looking for future studies?
Notify Me22 year and older
All sexes
Interventional
Not applicable
Berkeley, California, 94705, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 weeks of a typical Western diet pattern. 48% carbohydrate, 15% protein, 37% fat.
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 9 weeks
Time frame: 14 weeks
Time frame: 9 weeks
Time frame: 14 weeks
Time frame: 9 weeks
Time frame: 14 weeks
Time frame: 9 weeks
Time frame: 14 weeks
Time frame: 9 weeks
Time frame: 14 weeks
Time frame: 9 weeks
Time frame: 14 weeks
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
Time frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
UCSF Benioff Children's Hospital Oakland
Other
Effects of a Modified Lower Carbohydrate, Higher Fat DASH Diet Plan on Plasma Lipids, Lipoprotein Particle Size, and Blood Pressure in Healthy Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06405880
Blood Pressure, Cardiovascular Disease
Edmonton, Alberta, Canada
View Trial DetailsNCT01562782
Body Weight, Cardiovascular Disease
New York, United States
View Trial DetailsNCT00768274
Acute Coronary Syndrome, Arterial Occlusive Diseases
Dallas, Texas, United States
View Trial DetailsNCT00508937
Cardiovascular Disease, Cardiovascular Diseases
Berkeley, California, United States
View Trial Details